Immunoblotting was performed to quantify CAMKK2 protein levels in the temporal cortex tissues derived from PD (N = 27, 5 female and 22 male) patients postmortem (Figures 5A, D). This evidence concerns the gene CAMKK2 and Parkinson disease.